Side Effect Scare Hits French Trials
Nature. 1982 Nov 11; 300(5888): 97-98.
The French Ministry of Health, acting on the advice of its scientific council, has halted clinical trials of interferon in cancer patients after four out of eleven recipients died of myocardial infarctions. Trials are expected to resume after the domestically produced drug stock is repurified and successfully retested. It has been suggested that council oversight should be extended to imported interferon and other experimental drugs which are now being used in human trials without the Ministry's control or knowledge. (KIE abstract)